3 min listen
New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
FromPri-Med Podcasts
New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
FromPri-Med Podcasts
ratings:
Length:
11 minutes
Released:
Nov 14, 2022
Format:
Podcast episode
Description
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
Released:
Nov 14, 2022
Format:
Podcast episode
Titles in the series (100)
ADD & ADHD in Children and Adults: Beyond Stimulants (FAQ): FAQ for ADD & ADHD in Children and Adults: Beyond Stimulants (Not for CME credit) Guest: Daniel Press, MD by Pri-Med Podcasts